DMD and Duchenne muscular dystrophy: To investigate the efficacy of ABE in treating the majority of DMD types caused by exon deletion mutations accounting for 70% of DMD patients, we herein generated a genetically humanized DMD mouse model by replacing mouse exon 50 and 51 with human DMD exon 50, modeling DMD deletion mutations and reliably recapitulating human DMD phenotypes.